Transgene SA TRGNF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 16.78% | 9.71% | -13.85% | -10.86% | -23.42% |
| Total Depreciation and Amortization | 4.34% | 13.18% | 6.96% | 4.13% | 15.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -140.12% | -143.53% | 157.12% | 155.63% | 966.84% |
| Change in Net Operating Assets | -167.59% | -190.29% | -125.36% | -124.70% | 47.30% |
| Cash from Operations | -11.69% | -21.17% | -316.00% | -305.10% | -2.10% |
| Capital Expenditure | -134.37% | -154.22% | 42.10% | 43.63% | 85.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5,902.02% | 6,395.88% | -16,296.69% | -15,865.23% | -159.34% |
| Cash from Investing | 3,062.32% | 3,313.97% | -6,436.98% | -6,265.65% | 56.76% |
| Total Debt Issued | -- | -- | -1.50% | -1.50% | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 98.54% |
| Issuance of Common Stock | -- | -- | 94,595.50% | 94,595.50% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.02% | -100.02% | 7.77% | 7.77% | 4,902.74% |
| Cash from Financing | -100.09% | -100.09% | 1,520.78% | 1,478.32% | 9.88% |
| Foreign Exchange rate Adjustments | 101.97% | 102.14% | -184.81% | -182.63% | -469.53% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2,517.62% | -2,722.16% | -918.35% | -896.85% | 131.10% |